Although there is considerable knowledge of how DNA damage triggers cell cycle arrest, DNA repair, and apoptosis, little was known about its potential role in immune responses. Recently, we showed that genotoxic stress and stalled DNA replication forks induce the expression of ligands for the NKG2D receptor found in natural killer cells and certain T cells, cell types that are able to attack tumor cells. Chronic activation of this response in tumor cells may contribute to immune recogni-tion, but it also imposes a selection mechanism for immune escape and malignant progression. This unique arm of the DNA damage response may have implications for understand-ing therapeutic responses, many of which induce the DNA damage response, and for desi...
Over the past decades it has become increas-ingly clear that the DnA damage response (DDR) plays a c...
Cells respond to genotoxic stress through a series of complex protein pathways called DNA damage res...
Current cancer therapies rely mainly on DNA damaging insults (irradiation, DNA alkylating agents, DN...
The DNA damage response (DDR) is an organized network of multiple interwoven components evolved to r...
Genome instability and immune evasion are both defining hallmarks of cancer. Tumorigenesis is freque...
Genotoxic or replicative stress triggers a DNA damage response (DDR) that induces cell cycle arrest,...
The DNA damage response (DDR) maintains the stability of a genome faced with genotoxic insults (exog...
Maintenance of genomic integrity is crucial for cell survival. As such, elegant DNA damage response ...
Natural killer (NK) cells recognize and kill cancer cells and infected cells by engaging cell surfac...
The natural killer group 2 member D (NKG2D) receptor and its family of NKG2D ligands (NKG2DLs) are k...
International audienceNKG2D and DNAM-1 are two activating receptors, present on the surface of NK ce...
The characteristic feature of healthy living organisms is the preservation of homeostasis. Compellin...
International audienceImmunotherapy has revolutionized cancer treatment and substantially improved p...
The human genome is constantly exposed to exogenous and endogenous DNA damaging factors that frequen...
The cell death response to DNA damage is discussed in this Perspectives piece with cancer as the bac...
Over the past decades it has become increas-ingly clear that the DnA damage response (DDR) plays a c...
Cells respond to genotoxic stress through a series of complex protein pathways called DNA damage res...
Current cancer therapies rely mainly on DNA damaging insults (irradiation, DNA alkylating agents, DN...
The DNA damage response (DDR) is an organized network of multiple interwoven components evolved to r...
Genome instability and immune evasion are both defining hallmarks of cancer. Tumorigenesis is freque...
Genotoxic or replicative stress triggers a DNA damage response (DDR) that induces cell cycle arrest,...
The DNA damage response (DDR) maintains the stability of a genome faced with genotoxic insults (exog...
Maintenance of genomic integrity is crucial for cell survival. As such, elegant DNA damage response ...
Natural killer (NK) cells recognize and kill cancer cells and infected cells by engaging cell surfac...
The natural killer group 2 member D (NKG2D) receptor and its family of NKG2D ligands (NKG2DLs) are k...
International audienceNKG2D and DNAM-1 are two activating receptors, present on the surface of NK ce...
The characteristic feature of healthy living organisms is the preservation of homeostasis. Compellin...
International audienceImmunotherapy has revolutionized cancer treatment and substantially improved p...
The human genome is constantly exposed to exogenous and endogenous DNA damaging factors that frequen...
The cell death response to DNA damage is discussed in this Perspectives piece with cancer as the bac...
Over the past decades it has become increas-ingly clear that the DnA damage response (DDR) plays a c...
Cells respond to genotoxic stress through a series of complex protein pathways called DNA damage res...
Current cancer therapies rely mainly on DNA damaging insults (irradiation, DNA alkylating agents, DN...